ISSN 1662-4009 (online)

ey0018.13 | Jean-Pierre Chanoine | ESPEYB18

13. Global Health for the Paediatric Endocrinologist

Chanoine Jean-Pierre

PrefaceWelcome to the 6th edition of this chapter on Global Health in Pediatric Endocrinology and Diabetes. As usual, the selected articles cover many aspects of our specialty. This year is important because we celebrate the 100th anniversary of the discovery of insulin by Sir Frederick Banting, Charles Best, John Macleod and James Collip at the University of Toronto in 1921. This discovery paved the way for the first administration...

ey0019.13 | Jean-Pierre Chanoine | ESPEYB19

13. Global Health for the Paediatric Endocrinologist

Chanoine Jean-Pierre

Introduction: For this 7th edition of the global health chapter of the Yearbook for pediatric endocrinology and diabetes, I was happy to see an increasing number of articles discussing direct or indirect access to healthcare. Indeed, in parallel to studies reporting clinical aspects of endocrine conditions and of diabetes that are specific to low- and middle-income countries, there is an abundance of articles that analyze the reasons for poor access to healthcare an...

ey0017.13 | Jean-Pierre Chanoine | ESPEYB17

13. Global Health for the Paediatric Endocrinologist

Chanoine Jean-Pierre

Preface Welcome to the 5th edition of this chapter on Global Health in Pediatric Endocrinology and Diabetes. As usual, the selected articles cover most aspects of pediatric endocrinology and diabetes. However, I particularly recommend the first 5 papers that are presented in the first section. They make us reflect on more philosophical aspects of our work as pediatric endocrinologists interested in global health....

ey0016.13 | (1) | ESPEYB16

13. Global Health for the Paediatric Endocrinologist

Chanoine Jean-Pierre , von Oettingen Julia

Preface: Welcome to the 4th edition of this section on Global Health in Pediatric Endocrinology and Diabetes. We again found a vast array of articles that are relevant to the ambitious 2030 Agenda for Sustainable Development adopted in 2015 by all United Nations member states. Pediatric Endocrinology specifically fits with Sustainable Development Goal 3: “Ensure healthy lives and promote well-being for all at all ages”, a Goal that focuses on non-communicable disease...

ey0015.13 | (1) | ESPEYB15

13. Global Health for the Paediatric Endocrinologist

Chanoine Jean-Pierre , von Oettingen Julia

Welcome to the 3rd edition of this chapter on Global Health in Pediatric Endocrinology and Diabetes. It is very comforting to witness the rapid increase in high quality research papers that challenge guidelines commonly made for and used in resource-rich settings and that propose new approaches based on the specific characteristics of resource-limited settings. We found many papers on the topic of Developmental Origins of Health and Disease/Type 2 diabetes, on conge...

ey0016.13-9 | Endocrinology: Disorders of Sexual Development | ESPEYB16

13.9. Incidence of disorders of sexual development in neonates in Ghana: prospective study

E Ameyaw , SB Asafo-Agyei , IA Hughes , M Zacharin , JP Chanoine

Arch Dis Child 2019;104:636–638. DOI: 10.1136/archdischild-2019-316986• Prospective cohort study of 9255 neonates at a tertiary care center in Ghana to determine the incidence of disorders of sexual development (DSD) using physical examination, ultrasound and 17-hydroxyprogesterone measurements.• The estimated incidence of a DSD was 28/10,00...

ey0015.13-11 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15

13.11 Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa

A Rowlands , E Ameyaw , F Rutagarama , J Dipsesalema , ES Majaliwa , J Mbogo , GD Ogle , JP Chanoine

To read the full abstract: Horm Res Paediatr. 2018; Jul 26:1-1As the global burden of non-communicable diseases (NCD) is rising to epidemic levels worldwide, efforts are underway to build capacity for childhood NCDs in low- and middle-income countries (LMICs), including among health care providers in pediatric endocrinology. With increased ability to recognize and diagnose pediatric endocrine conditi...

ey0020.11 | Jean-Pierre Chanoine, Diane Stafford | ESPEYB20

11. Global Health for the Paediatric Endocrinologist

Chanoine1 Jean-Pierre , Stafford2 Diane

In this 8th edition of the Yearbook of Pediatric Endocrinology and diabetes Global Health chapter, we are happy to see increased continuity across all aspects of care especially in pediatric diabetes: from improved access to medicines to e-learning, digital health, epidemiological data specific to low- and middle-income countries and treatment protocols that meet the needs of underserved populations. From a half-full/half-empty glass perspective, we see reasons for hope....

ey0021.13-8 | Endocrinology | ESPEYB21

13.8. Experiences and challenges with congenital hypothyroidism newborn screening in Indonesia: a national cross-sectional survey

AB Pulungan , HA Puteri , M Faizi , PL Hofman , A Utari , JP Chanoine

Brief Summary: This cross-sectional survey of healthcare professionals and administrators in Indonesia investigated the many challenges raised during implementation of a national newborn screening program for congenital hypothyroidism (CH).Despite initiation of Newborn Screening (NBS) for CH in Indonesia between 2000 and 2010 and expansion more recently, only 2.3% of newborns were screened in 2022. This national survey aimed to identify barriers to wider...

ey0019.13-6 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.6. Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean region: it takes a village…

A Rowlands , A Deeb , A Ladjouze , RT Hamza , SA Musa , J Raza , F Jennane , A Abu-Libdeh , JP Chanoine , the GPED CAH Working Group

jchanoine@cw.bc.ca BMJ Global Health 2021;6:e007195. doi: 10.1136/bmjgh-2021-007195Brief Summary: This review found that access to oral fludrocortisone and hydrocortisone remains suboptimal in the WHO Eastern Mediterranean Region. Improvement requires a collaboration between health professionals, families of patients, health authorities, pharmaceutica...